Skip to content
Juris 340B Solutions
Insights

When policy moves, our analysis lands within 48 hours.

Not a news feed. Analysis of what a development actually means for a covered entity operating a program — written by the people who then have to advise on it.

Book a consultationBrowse resources

At a glance

01Response time
48 hours
02Cadence
2–4 per week
03Newsletter
Monthly digest
04Paywall
None
Why we publish this

Policy moves fast. Your program should not find out last.

Contract pharmacy restrictions, state legislation, the rebate model, CMS reimbursement — when something changes, our goal is for the analysis to reach clients within 48 hours.

Recent

Latest analysis

Regulatory01

The 25 Areas HRSA Actually Examines in a 340B Audit

A plain breakdown of the six categories HRSA findings cluster in, and what evidence each one requires.

Analysis · Aug 2026
Regulatory02

The 340B Rebate Model: What to Prepare Now

What changes operationally if drugs move from up-front discount to rebate, and why the cash-flow question matters more than the compliance question at first.

Analysis · Jul 2026
Operations03

What Your TPA Won't Tell You About Its Own Accuracy

A third-party administrator runs split billing — it doesn't audit itself. Here's what an independent review actually checks.

Practice note · Jul 2026
Infusion04

Site-of-Care and White Bagging: What Infusion Programs Are Up Against

Why site-neutral payment pressure and white/brown bagging both point in the same direction for infusion economics — and how to model your exposure.

Analysis · Jun 2026
Coming soon05

New analysis in progress

We're preparing our next piece of 340B analysis — check back shortly.

Publishing soon
Coming soon06

New analysis in progress

We're preparing our next piece of 340B analysis — check back shortly.

Publishing soon
Editorial structure

What we write about, and why

Our content is organized into eight topic clusters, each supporting a pillar page. This is the structure behind the site, published openly because it is also useful to anyone building a 340B knowledge function internally.

  • 01340B fundamentals

    Focus
    Program mechanics, eligibility, terminology, how the pieces fit together
    Supports
    What is 340B? · How 340B works · Covered entities

  • 02Compliance & audits

    Focus
    HRSA audit criteria, findings analysis, self-audit method, corrective action
    Supports
    HRSA audits · Mock audits · Compliance management

  • 03Contract pharmacy

    Focus
    Arrangements, oversight, manufacturer restrictions, state protection laws
    Supports
    Contract pharmacy explained · Contract pharmacy management

  • 04Medicaid & duplicate discounts

    Focus
    Carve-in decisions, MEF mechanics, managed care by state
    Supports
    Duplicate discounts · Split billing

  • 05Policy & legislation

    Focus
    Federal proposals, rebate model, state law, litigation, CMS reimbursement
    Supports
    Insights · Resource center

  • 06Entity-specific operations

    Focus
    How the program differs for hospitals, health centers, CAHs, Ryan White clinics
    Supports
    Each entity type page

  • 07Infusion & site of care

    Focus
    Chair economics, white bagging, site-neutral policy, feasibility
    Supports
    Infusion consulting · Oncology & infusion

  • 08Program leadership

    Focus
    Staffing, governance, board reporting, building internal capability
    Supports
    About · Our process · Resource center

Next step

Want the monthly digest?

One email a month with what actually changed and what it means operationally. No drip sequence, no sales content, unsubscribe in one click.

Subscribe to the digestBrowse the resource center
Talk to an Expert